p53-based anti-cancer therapies: An empty promise?

Related Experiment Video

Updated: Jun 18, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Nikolas Desilet1, Tessa N Campbell, Francis Y M Choy

  • 1Department of Biology, University of Victoria, BC, Canada.

Current Issues in Molecular Biology
|November 18, 2009
PubMed

Insights

The p53 protein is crucial for cancer research but has not yielded successful treatments. New strategies involving combination therapies and microRNA regulation may unlock its anti-cancer potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 protein, discovered in 1979, is vital for cellular functions like stress response and apoptosis.
  • Mutations in p53 are prevalent in numerous human cancers, suggesting its therapeutic importance.
  • Despite extensive research, p53-targeted therapies have not yet achieved clinical success.

Purpose of the Study:

  • To review the challenges and recent advancements in targeting the p53 pathway for cancer treatment.
  • To explore novel therapeutic strategies that could fulfill the promise of p53 in oncology.

Main Methods:

  • Literature review of p53 research over the past three decades.
  • Analysis of emerging therapeutic approaches including small molecule combination therapies and microRNA regulation.
  • Examination of clinical trial designs and the role of p53 in stem cell biology.

Main Results:

  • The p53 pathway, while extensively studied, has faced significant hurdles in clinical translation.
  • Emerging research highlights the potential of combination therapies and microRNA-based strategies.
  • The role of p53 in stem cell regulation presents new avenues for therapeutic development.

Conclusions:

  • Targeting the p53 pathway remains a critical goal in cancer research.
  • Innovative approaches such as combination therapies, microRNA regulation, and understanding p53's role in stem cells offer renewed hope.
  • Further research and optimized clinical trial designs are necessary to harness the full therapeutic potential of p53 against cancer.

More Related Videos

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...